These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 9237176

  • 1. HBME-1 immunostaining in thyroid fine-needle aspirations: a useful marker in the diagnosis of carcinoma.
    Sack MJ, Astengo-Osuna C, Lin BT, Battifora H, LiVolsi VA.
    Mod Pathol; 1997 Jul; 10(7):668-74. PubMed ID: 9237176
    [Abstract] [Full Text] [Related]

  • 2. The role of immunolocalization of CD57 and GLUT-1 in cell blocks in fine-needle aspiration diagnosis of papillary thyroid carcinoma.
    Chandan VS, Faquin WC, Wilbur DC, Khurana KK.
    Cancer; 2006 Oct 25; 108(5):331-6. PubMed ID: 16944537
    [Abstract] [Full Text] [Related]

  • 3. Fine-needle aspiration biopsy of papillary thyroid carcinoma: diagnostic utility of cytokeratin 19 immunostaining.
    Nasser SM, Pitman MB, Pilch BZ, Faquin WC.
    Cancer; 2000 Oct 25; 90(5):307-11. PubMed ID: 11038428
    [Abstract] [Full Text] [Related]

  • 4. HBME-1 and CK19 are highly discriminatory in the cytological diagnosis of papillary thyroid carcinoma.
    Nga ME, Lim GS, Soh CH, Kumarasinghe MP.
    Diagn Cytopathol; 2008 Aug 25; 36(8):550-6. PubMed ID: 18618720
    [Abstract] [Full Text] [Related]

  • 5. Immunostaining for thyroid transcription factor-1 on fine-needle aspiration specimens of lung tumors: a comparison of direct smears and cell block preparations.
    Liu J, Farhood A.
    Cancer; 2004 Apr 25; 102(2):109-14. PubMed ID: 15098255
    [Abstract] [Full Text] [Related]

  • 6. HBME-1 expression in follicular tumor of the thyroid: an investigation of whether it can be used as a marker to diagnose follicular carcinoma.
    Ito Y, Yoshida H, Tomoda C, Miya A, Kobayashi K, Matsuzuka F, Kakudo K, Kuma K, Miyauchi A.
    Anticancer Res; 2005 Apr 25; 25(1A):179-82. PubMed ID: 15816536
    [Abstract] [Full Text] [Related]

  • 7. [HBME-1 immunostaining in thyroid pathology].
    Rigau V, Martel B, Evrard C, Rousselot P, Galateau-Salle F.
    Ann Pathol; 2001 Feb 25; 21(1):15-20. PubMed ID: 11223556
    [Abstract] [Full Text] [Related]

  • 8. Applications of monoclonal antibodies in clinical cytology as exemplified by studies with monoclonal antibody B72.3. The George N. Papanicolaou award lecture.
    Johnston WW.
    Acta Cytol; 1987 Feb 25; 31(5):537-56. PubMed ID: 3314301
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Usefulness of HBME-1, cytokeratin 19 and galectin-3 immunostaining in the diagnosis of thyroid malignancy.
    de Matos PS, Ferreira AP, de Oliveira Facuri F, Assumpção LV, Metze K, Ward LS.
    Histopathology; 2005 Oct 25; 47(4):391-401. PubMed ID: 16178894
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2.
    Cano G, Milanezi F, Leitão D, Ricardo S, Brito MJ, Schmitt FC.
    Diagn Cytopathol; 2003 Oct 25; 29(4):207-11. PubMed ID: 14506673
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Expression of cytokeratin 19, HBME-1 and galectin-3 in neoplastic and nonneoplastic thyroid lesions.
    Mataraci EA, Ozgüven BY, Kabukçuoglu F.
    Pol J Pathol; 2012 Mar 25; 63(1):58-64. PubMed ID: 22535608
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Utility of galectin 3 expression in thyroid aspirates as a diagnostic marker in differentiating benign from malignant thyroid neoplasms.
    Aron M, Kapila K, Verma K.
    Indian J Pathol Microbiol; 2006 Jul 25; 49(3):376-80. PubMed ID: 17001889
    [Abstract] [Full Text] [Related]

  • 18. Application of the immunoperoxidase technique to cell block preparations from fine needle aspirates.
    Kung IT, Chan SK, Lo ES.
    Acta Cytol; 1990 Jul 25; 34(3):297-303. PubMed ID: 2160769
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Phenotypic characterization of lung cancers in fine needle aspiration biopsies using monoclonal antibody B72.3.
    Johnston WW, Szpak CA, Thor A, Schlom J.
    Cancer Res; 1986 Dec 25; 46(12 Pt 1):6462-70. PubMed ID: 3022920
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.